PBMs Must Prepare For Revival Of Drug Price Transparency Requirements

Experts say PBMs should become familiar with transparency rules and prepare to release data, although more legal wrangling could occur.

Net drug price disclosure "is going to happen," said Chris O'Dell of Turquoise Health. (Shutterstock)
Key Takeaways
  • PBM price transparency rules are not expected to fall away with President Trump wanting to ensure they are enforced.
  • More legal wrangling over the rules may occur, but may be impacted by the broader PBM reform landscape.
  • Experts said PBMs should become familiar with the transparency standards to prepare for data to be released.

While a previous effort to force the disclosure of net drug prices was scuttled amid legal challenges, President Donald Trump recently made it clear that he hopes to revisit the...

“There’s no more hope that this will go away,” said Chris O’Dell, senior vice president of market solutions at Turquoise Health, a company that cleans and aggregates pricing data from...

More from PBMs

‘Tectonic’ Arkansas PBM Legislation May Upend Industry

 
• By 

Industry will fight hard to prevent other states or the federal government from adopting measures similar to Arkansas' law preventing PBMs from owning pharmacies.

House Budget Bill Includes Delayed Orphan Fix, Also Risks Downstream Cell and Gene Coverage

 

The first two classes of negotiated drugs under the Inflation Reduction Act would not benefit from a rare disease adjustment House Republicans included in their reconciliation package.

PBMs No Longer Profit From Rebates But Plans Benefit; Should Sponsors Push More For Reform?

 
• By 

Employers and other health plan sponsors may need to push for better targeted reforms that lower cost sharing for patients.

PBMs Must Prepare For Revival Of Drug Price Transparency Requirements

 

Experts say PBMs should become familiar with transparency rules and prepare to release data, although more legal wrangling could occur.

More from Market Access

Spain Slashes Wait Between EU Drug Authorization And Financing Decisions

 

Spanish authorities say that that timelines for drug reimbursement decisions can be improved further with the right submissions from companies.

Spain Beats England To Tevimbra Reimbursement Recommendations

 

Spanish authorities have published more pricing and reimbursement reports as part of a new drive to increase transparency.

‘Tectonic’ Arkansas PBM Legislation May Upend Industry

 
• By 

Industry will fight hard to prevent other states or the federal government from adopting measures similar to Arkansas' law preventing PBMs from owning pharmacies.